Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BEAM |
---|---|---|
09:32 ET | 6552 | 25.16 |
09:36 ET | 200 | 25.36 |
09:38 ET | 1240 | 25.65 |
09:39 ET | 2500 | 25.7775 |
09:41 ET | 503 | 25.665 |
09:43 ET | 800 | 25.69 |
09:45 ET | 200 | 25.605 |
09:48 ET | 300 | 25.57 |
09:50 ET | 23782 | 25.405 |
09:52 ET | 3700 | 25.41 |
09:54 ET | 1648 | 25.38 |
09:56 ET | 1200 | 25.49 |
09:59 ET | 100 | 25.39 |
10:01 ET | 800 | 25.24 |
10:03 ET | 1064 | 25.435 |
10:06 ET | 800 | 25.29 |
10:08 ET | 500 | 25.37 |
10:10 ET | 250 | 25.33 |
10:12 ET | 3300 | 25.39 |
10:14 ET | 2743 | 25.24 |
10:15 ET | 1115 | 25.2 |
10:17 ET | 300 | 25.18 |
10:21 ET | 900 | 25.22 |
10:24 ET | 700 | 25.29 |
10:26 ET | 687 | 25.27 |
10:28 ET | 1600 | 25.3 |
10:30 ET | 700 | 25.26 |
10:32 ET | 200 | 25.25 |
10:33 ET | 1000 | 25.19 |
10:35 ET | 1000 | 25.23 |
10:37 ET | 3140 | 25.07 |
10:39 ET | 920 | 25.11 |
10:42 ET | 1000 | 25.1497 |
10:44 ET | 200 | 25.13 |
10:46 ET | 700 | 25.22 |
10:48 ET | 496 | 25.23 |
10:50 ET | 2977 | 25.29 |
10:51 ET | 1187 | 25.24 |
10:53 ET | 300 | 25.18 |
10:55 ET | 300 | 25.155 |
10:57 ET | 499 | 25.07 |
11:00 ET | 5922 | 25.145 |
11:02 ET | 300 | 25.3 |
11:04 ET | 707 | 25.16 |
11:06 ET | 1275 | 25.135 |
11:08 ET | 300 | 25.155 |
11:09 ET | 1202 | 25.15 |
11:11 ET | 785 | 25.215 |
11:13 ET | 1556 | 25.19 |
11:15 ET | 1615 | 25.25 |
11:18 ET | 300 | 25.28 |
11:20 ET | 1300 | 25.295 |
11:22 ET | 1321 | 25.305 |
11:24 ET | 455 | 25.28 |
11:26 ET | 805 | 25.27 |
11:27 ET | 1400 | 25.25 |
11:29 ET | 700 | 25.23 |
11:31 ET | 400 | 25.26 |
11:33 ET | 1618 | 25.33 |
11:36 ET | 500 | 25.27 |
11:38 ET | 900 | 25.21 |
11:40 ET | 700 | 25.15 |
11:42 ET | 700 | 25.15 |
11:44 ET | 1300 | 25.18 |
11:45 ET | 400 | 25.13 |
11:47 ET | 730 | 25.19 |
11:49 ET | 855 | 25.22 |
11:51 ET | 500 | 25.22 |
11:54 ET | 300 | 25.21 |
11:56 ET | 200 | 25.16 |
11:58 ET | 400 | 25.25 |
12:00 ET | 3400 | 25.265 |
12:02 ET | 3078 | 25.29 |
12:03 ET | 510 | 25.35 |
12:05 ET | 400 | 25.32 |
12:07 ET | 1069 | 25.31 |
12:09 ET | 600 | 25.325 |
12:12 ET | 400 | 25.295 |
12:14 ET | 1805 | 25.26 |
12:16 ET | 2500 | 25.18 |
12:18 ET | 200 | 25.18 |
12:20 ET | 300 | 25.2 |
12:21 ET | 200 | 25.15 |
12:23 ET | 600 | 25.165 |
12:25 ET | 200 | 25.12 |
12:27 ET | 700 | 25.1231 |
12:30 ET | 1156 | 25.13 |
12:32 ET | 600 | 25.04 |
12:34 ET | 1521 | 25.12 |
12:36 ET | 100 | 25.15 |
12:38 ET | 300 | 25.1 |
12:39 ET | 500 | 25.14 |
12:41 ET | 100 | 25.16 |
12:45 ET | 500 | 25.16 |
12:48 ET | 400 | 25.13 |
12:50 ET | 400 | 25.1 |
12:52 ET | 625 | 25.11 |
12:54 ET | 600 | 25.1 |
12:56 ET | 300 | 25.1 |
12:57 ET | 100 | 25.1 |
12:59 ET | 200 | 25.09 |
01:01 ET | 900 | 25.135 |
01:03 ET | 3055 | 25.21 |
01:06 ET | 300 | 25.2175 |
01:08 ET | 1780 | 25.23 |
01:10 ET | 473 | 25.14 |
01:12 ET | 1000 | 25.16 |
01:14 ET | 533 | 25.16 |
01:15 ET | 500 | 25.155 |
01:17 ET | 1394 | 25.205 |
01:19 ET | 200 | 25.205 |
01:21 ET | 400 | 25.23 |
01:24 ET | 226 | 25.2207 |
01:26 ET | 1800 | 25.2101 |
01:28 ET | 100 | 25.21 |
01:30 ET | 300 | 25.27 |
01:32 ET | 1310 | 25.3 |
01:33 ET | 1000 | 25.26 |
01:35 ET | 390 | 25.23 |
01:37 ET | 100 | 25.23 |
01:39 ET | 400 | 25.17 |
01:42 ET | 300 | 25.135 |
01:44 ET | 1170 | 25.12 |
01:46 ET | 323 | 25.14 |
01:48 ET | 600 | 25.19 |
01:50 ET | 200 | 25.21 |
01:51 ET | 300 | 25.22 |
01:53 ET | 500 | 25.27 |
01:55 ET | 553 | 25.275 |
01:57 ET | 100 | 25.27 |
02:00 ET | 100 | 25.24 |
02:02 ET | 500 | 25.265 |
02:04 ET | 201 | 25.23 |
02:06 ET | 100 | 25.24 |
02:09 ET | 406 | 25.24 |
02:11 ET | 200 | 25.22 |
02:13 ET | 1422 | 25.27 |
02:15 ET | 1000 | 25.3 |
02:18 ET | 970 | 25.29 |
02:20 ET | 400 | 25.23 |
02:24 ET | 327 | 25.18 |
02:26 ET | 127 | 25.14 |
02:27 ET | 519 | 25.045 |
02:29 ET | 600 | 25.03 |
02:31 ET | 1419 | 25.075 |
02:33 ET | 5701 | 25.04 |
02:36 ET | 415 | 25.045 |
02:38 ET | 5158 | 25 |
02:40 ET | 400 | 25 |
02:42 ET | 400 | 24.985 |
02:44 ET | 602 | 25.02 |
02:45 ET | 600 | 24.99 |
02:47 ET | 500 | 25.05 |
02:51 ET | 500 | 25.06 |
02:54 ET | 200 | 25.05 |
02:56 ET | 508 | 25.02 |
02:58 ET | 1800 | 25.08 |
03:00 ET | 900 | 25.13 |
03:02 ET | 400 | 25.12 |
03:03 ET | 200 | 25.08 |
03:05 ET | 300 | 25.08 |
03:07 ET | 200 | 25.085 |
03:09 ET | 200 | 25.105 |
03:12 ET | 2264 | 25.04 |
03:14 ET | 804 | 25.04 |
03:16 ET | 669 | 25.045 |
03:18 ET | 200 | 25.015 |
03:20 ET | 1421 | 24.98 |
03:21 ET | 300 | 24.94 |
03:23 ET | 905 | 24.97 |
03:25 ET | 500 | 24.94 |
03:27 ET | 455 | 24.95 |
03:30 ET | 350 | 24.9999 |
03:32 ET | 1500 | 24.98 |
03:34 ET | 1702 | 24.885 |
03:36 ET | 2586 | 24.815 |
03:38 ET | 2723 | 24.795 |
03:39 ET | 500 | 24.78 |
03:41 ET | 6971 | 24.75 |
03:43 ET | 3273 | 24.8 |
03:45 ET | 345 | 24.805 |
03:48 ET | 500 | 24.795 |
03:50 ET | 2779 | 24.77 |
03:52 ET | 3576 | 24.8 |
03:54 ET | 4121 | 24.75 |
03:56 ET | 15465 | 24.9 |
03:57 ET | 22913 | 25.09 |
03:59 ET | 205989 | 25.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Beam Therapeutics Inc | 2.1B | -14.2x | --- |
Galapagos NV | 1.9B | 54.8x | --- |
Genmab A/S | 15.8B | 19.3x | +22.71% |
Catalyst Pharmaceuticals Inc | 2.4B | 36.7x | --- |
Veracyte Inc | 2.6B | -45.4x | --- |
Maravai LifeSciences Holdings Inc | 2.1B | -8.4x | --- |
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
---|---|
Revenue (TTM) | $352.6M |
Shares Outstanding | 82.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.85 |
EPS | $-1.76 |
Book Value | $12.02 |
P/E Ratio | -14.2x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.